Antitumor and Immune-Enhancing Activity of Chickpea Peptides in Hepatoma H22-Bearing Mice

Zhaohui Xue

2012-01-01

Abstract:Objective: To find out whether chickpea peptides has antitumor and immune-enhancing activity in hepatoma H22-bearing mice.Methods: KM mice were randomly divided to normal control group,positive control group(PC),tumor control group and chickpea peptide groups at the doses of 50,100 mg/(kg·d) and 200 mg/(kg·d).The H22-bearing mice were treated with chickpea peptide and Cy by gavage at the volume of 0.2 mL/mouse per day for 10 consecutive days.Distilled water was used for the normal control group.The body weight,tumor growth,tumor inhibitory rate,thymus index,spleen index,cell-mediated immune functions including lymphocyte proliferation,peritoneal macrophage phagocytosis and splenic lymphocytes were detected at 24 h after the last administration.Results: An inhibitory tend of tumor growth was observed in the chickpea peptide group.Compared with the tumor control group,a significant increase in relative spleen weight,delayed-type hypersensitivity(DTH),peritoneal macrophage phagocytotic activity and splenic lymphocyte in the chickpea groups was also observed.However,no dose-dependent effect was achieved.Conclusion: Peptides derived from chickpea have anti-tumor activity probably by enhancing immune functions in hepatoma H22-bearing mice.The detailed mechanism remains to be further studied.